were subcutaneously inoculated into the left backs of C57BL/6 mice and MGlu-HPG-modified liposomes containing 50 μg of OVA proteins (squares), MGlu-HPG-modified liposomes containing 50 μg of OVA-I peptides (circles), were subcutaneously administered into the right backs of the mice twice on days 6 and 13. Mice immunized with PBS (dotted line) were shown as controls. Change in tumor volume (a) and survival of mice (b) were shown. Mice were sacrificed when tumor volumes became over 2500 mm 3 . * p < 0.05 compared with PBS-treated group. Results of Log-rank test was shown in Table S2 . 
